Potential Biomarkers in Diabetic Retinopathy

Area of Science:

• Ophthalmology
• Endocrinology
• Biochemistry

Background:

• Diabetic retinopathy is a major diabetes complication leading to vision loss.
• Early detection is often missed, resulting in irreversible eye damage and blindness.
• Current treatments have limitations, necessitating improved diagnostic approaches.

Purpose of the Study:

• To review and identify potential biomarkers for diabetic retinopathy.
• To explore novel biomarkers for improved diagnosis and management.
• To assess the role of biomarkers in understanding diabetic retinopathy pathogenesis.

Main Methods:

• Literature search using terms like "Diabetic retinopathy" and "Biomarkers" in databases such as PubMed and Scopus.
• Inclusion criteria focused on detectable biomarkers relevant to diabetic retinopathy.
• Exclusion criteria removed repetitive or duplicated biomarker information.

Main Results:

• Biomarkers identified include inflammatory (TNF-α, MCP-1, TGF-β), antioxidant (NADPH oxidase), nucleic acid (PARP-α, Apelin, Oncofetal), and enzyme (ceruloplasmin, PKC) types.
• Miscellaneous biomarkers like erythropoietin were also noted.
• These identified biomarkers show significant potential in tracking diabetic retinopathy progression.

Conclusions:

• The identified biomarkers play a critical role in diabetic retinopathy pathogenesis.
• These biomarkers can serve as valuable targets for developing new therapeutic strategies.
• Biomarker discovery offers a promising avenue for early diagnosis and effective management of diabetic retinopathy.